Liposomal Nω-hydroxy-l-norarginine, a proof-of-concept: Arginase inhibitors can be incorporated in liposomes while retaining their therapeutic activity ex vivo

Update your browser to view ScienceDirect.

Request details:

Request ID: 8e3834daca61eb28-LAX
IP: 116.62.10.13
UTC time: 2024-11-16T14:35:15+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4